FANCD2 and chronic myelogenous leukemia, BCR-ABL1 positive: As this mutation was shared by a majority of (98.3%) AP-CML patients but not CP-CML patients or any of the healthy controls from genomic databases, it suggests the mutated FANCD2 gene’s association with early disease progression in CML.